{"schema_version":"secwatch.filing_event.v1","accession":"0001339970-26-000068","form_type":"8-K","ticker":"ATYR","cik":"0001339970","company_name":"aTYR PHARMA INC","filed_at":"2026-10-16T20:02:31+00:00","discovered_at":"2026-10-16T20:03:00.343767+00:00","generated_at":"2026-10-16T20:03:03.428607+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.45,"calibrated_materiality_score":0.45,"confidence":"high","headline":"aTyr Pharma holders approve reverse stock split of 1-for-10 to 1-for-50 at Board's discretion","bullets":["Proposal 1 approved: alternate charter amendments let the Board effect a reverse split at any ratio between 1-for-10 and 1-for-50, inclusive, in its sole discretion.","Vote tally: 52,451,734 for, 5,234,645 against, 228,991 abstained, no broker non-votes.","57,915,370 shares, or about 59.04% of shares outstanding, were represented at the October 16, 2026 Special Meeting.","Record date was September 4, 2026, with 98,087,425 shares of common stock outstanding and entitled to vote.","Filing does not state a split ratio, timing, or effective date; those remain subject to future Board determination."],"urls":{"canonical":"https://secwatch.observer/filing/0001339970-26-000068","json":"https://secwatch.observer/filing/0001339970-26-000068.json","markdown":"https://secwatch.observer/filing/0001339970-26-000068.md","text":"https://secwatch.observer/filing/0001339970-26-000068.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1339970/000133997026000068/0001339970-26-000068-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1339970/000133997026000068/atyr-20261016.htm"},"model":{"generated_by":"deepseek-v4.1-flash:cloud@v2","generated_at":"2026-10-16T20:03:03.428607+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}